Filana Therapeutics
FLNA
153 hedge funds and large institutions have $315M invested in Filana Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 46 increasing their positions, 38 reducing their positions, and 16 closing their positions.
94% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 16
46% more capital invested
Capital invested by funds: $215M → $315M (+$99.4M)
44% more call options, than puts
Call options by funds: $81.5M | Put options by funds: $56.7M
21% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 38
9% more funds holding
Funds holding: 140 → 153 (+13)
2.34% more ownership
Funds ownership: 30.83% → 33.17% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$10.6M |
| 2 |
Jane Street
New York
|
+$7.62M |
| 3 |
BlackRock
New York
|
+$4.19M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$3.13M |
| 5 |
Goldman Sachs
New York
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$8.19M |
| 2 |
SG Americas Securities
New York
|
-$3.89M |
| 3 |
SC
Sculptor Capital
New York
|
-$3.69M |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$2.95M |
| 5 |
CF
Cantor Fitzgerald
New York
|
-$2.84M |
FLNA Hedge Fund Activity: Q4 2023 in Review
153 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2023, worth a combined $315M — up 46% from $215M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FLNA positions and 16 closed out — a net gain of 15 holders — while 46 added to existing stakes and 38 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $10.6M. The largest seller was Bank of America, cutting an estimated $8.19M.
- 153 institutional investors held Filana Therapeutics (FLNA) as of Q4 2023, up from 140 in Q3 2023.
- Funds reported $315M of Filana Therapeutics stock for Q4 2023, up 46% quarter-over-quarter.
- 31 funds opened new Filana Therapeutics positions in Q4 2023 and 16 closed out, a net change of +15 holders.
- The largest Filana Therapeutics buyer in Q4 2023 was Cowen and Company, an estimated $10.6M added.
- The largest Filana Therapeutics seller in Q4 2023 was Bank of America, an estimated $8.19M sold.
Based on aggregated 13F filings for Q4 2023.